92 related articles for article (PubMed ID: 9122275)
21. The serotonin aldehyde, 5-HIAL, oligomerizes alpha-synuclein.
Jinsmaa Y; Cooney A; Sullivan P; Sharabi Y; Goldstein DS
Neurosci Lett; 2015 Mar; 590():134-7. PubMed ID: 25637699
[TBL] [Abstract][Full Text] [Related]
22. Alterations of serotonin neurotransmission and inhibition of mouse killing behavior: II. Effects of selective and reversible monoamine oxidase inhibitors of type A.
Isel F; Ciesielski L; Gobaille S; Molina V; Mandel P
Pharmacol Biochem Behav; 1988 Jan; 29(1):97-104. PubMed ID: 2832858
[TBL] [Abstract][Full Text] [Related]
23. Substituted phenoxyalkylpiperazines as dopamine D3 receptor ligands.
Laszlovszky I; Acs T; Kiss B; Domány G
Pharmazie; 2001 Apr; 56(4):287-9. PubMed ID: 11338664
[TBL] [Abstract][Full Text] [Related]
24. Central serotonin involvement in the elaboration of the startle reaction in rats.
Fechter LD
Pharmacol Biochem Behav; 1974; 2(2):161-71. PubMed ID: 4275271
[No Abstract] [Full Text] [Related]
25. Novel benzothiazolin-2-one and benzoxazin-3-one arylpiperazine derivatives with mixed 5HT1A/D2 affinity as potential atypical antipsychotics.
Taverne T; Diouf O; Depreux P; Poupaert JH; Lesieur D; Guardiola-Lemaître B; Renard P; Rettori MC; Caignard DH; Pfeiffer B
J Med Chem; 1998 Jun; 41(12):2010-8. PubMed ID: 9622542
[TBL] [Abstract][Full Text] [Related]
26. Comparing sertindole to other new generation antipsychotics on preferential dopamine output in limbic versus striatal projection regions: mechanism of action.
Hertel P
Synapse; 2006 Dec; 60(7):543-52. PubMed ID: 16952163
[TBL] [Abstract][Full Text] [Related]
27. Oseltamivir (Tamiflu) increases dopamine levels in the rat medial prefrontal cortex.
Yoshino T; Nisijima K; Shioda K; Yui K; Kato S
Neurosci Lett; 2008 Jun; 438(1):67-9. PubMed ID: 18457919
[TBL] [Abstract][Full Text] [Related]
28. Reproductive experience modifies dopaminergic function, serum levels of prolactin, and macrophage activity in female rats.
Carvalho-Freitas MI; Anselmo-Franci JA; Teodorov E; Nasello AG; Palermo-Neto J; Felicio LF
Life Sci; 2007 Jun; 81(2):128-36. PubMed ID: 17574628
[TBL] [Abstract][Full Text] [Related]
29. [Combined effect of amphetamine and midantan on the dopaminergic transmission in the striatum of freely moving rats].
Afanas'ev II; Dvorkina ML; Raevskiĭ KS
Eksp Klin Farmakol; 2003; 66(1):3-7. PubMed ID: 12683071
[TBL] [Abstract][Full Text] [Related]
30. Regionally specific changes in central brain monoamine levels by 2,4-dichlorophenoxyacetic acid in acute treated rats.
Bortolozzi A; Duffard RO; Rubio M; Sturtz N; Evangelista de Duffard AM
Neurotoxicology; 1998 Dec; 19(6):839-51. PubMed ID: 9863773
[TBL] [Abstract][Full Text] [Related]
31. Isoflurane anesthesia induces biphasic effect on dopamine release in the rat striatum.
Adachi YU; Yamada S; Satomoto M; Higuchi H; Watanabe K; Kazama T
Brain Res Bull; 2005 Oct; 67(3):176-81. PubMed ID: 16144652
[TBL] [Abstract][Full Text] [Related]
32. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
[TBL] [Abstract][Full Text] [Related]
33. [Role of the pituitary in modulating the effect of the dopaminergic and serotoninergic systems on the immune response].
Al'perina EL; Idova GV; Devoĭno LV
Fiziol Zh SSSR Im I M Sechenova; 1985 Nov; 71(11):1428-32. PubMed ID: 3002871
[TBL] [Abstract][Full Text] [Related]
34. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
Hewton R; Salem A; Irvine RJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
[TBL] [Abstract][Full Text] [Related]
35. Role of aminergic (serotonin and dopamine) systems in the embryogenesis and different embryonic behaviors of the pond snail, Lymnaea stagnalis.
Filla A; Hiripi L; Elekes K
Comp Biochem Physiol C Toxicol Pharmacol; 2009 Jan; 149(1):73-82. PubMed ID: 18682301
[TBL] [Abstract][Full Text] [Related]
36. Proceedings: The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
Grahame-Smith DG; Green AR
Br J Pharmacol; 1974 Mar; 50(3):443P-446P. PubMed ID: 4277620
[No Abstract] [Full Text] [Related]
37. Brain monoamine metabolism in the mouse during the immediate post-partum period.
Greengrass PM; Tonge SR
Br J Pharmacol; 1972 Nov; 46(3):533P-534P. PubMed ID: 4266344
[No Abstract] [Full Text] [Related]
38. Effects of Semax on dopaminergic and serotoninergic systems of the brain.
Eremin KO; Kudrin VS; Grivennikov IA; Miasoedov NF; Rayevsky KS
Dokl Biol Sci; 2004; 394():1-3. PubMed ID: 15088389
[No Abstract] [Full Text] [Related]
39. The influence of quipazine on the turnover rate of serotonin.
Grabowska M; Antkiewicz L; Michaluk J
Biochem Pharmacol; 1974 Nov; 23(22):3211-2. PubMed ID: 4441411
[No Abstract] [Full Text] [Related]
40. Evidence for the functional interaction of two central neurotransmitters.
Jacobs BL
Psychopharmacologia; 1974; 39(1):81-6. PubMed ID: 4153732
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]